Business Idea
competitors.comparison.backToList
Tempus Labs logo

Tempus Labs

Tier 1
health
ai
https://www.tempus.com

Tempus Labs leverages artificial intelligence and precision medicine to improve cancer care and other healthcare outcomes.

Tempus Labs is a health technology company founded to modernize cancer care and healthcare at large by using data and artificial intelligence. The company analyzes clinical and molecular data at scale to help physicians make real-time, data-driven decisions. Tempus provides genomic testing and AI-powered data analytics to accelerate the development of novel therapeutics, optimize patient care, and enable more personalized treatment strategies.

competitors.competitorDetail.metrics.missionStatement

To help usher in an era of precision medicine to make healthcare more efficient and effective.

competitors.competitorDetail.metrics.visionStatement

To improve patient outcomes by combining the power of artificial intelligence and real-world evidence.

competitors.competitorDetail.overview

competitors.competitorDetail.metrics.foundedYear

2015

competitors.competitorDetail.metrics.ceo

Eric Lefkofsky

competitors.competitorDetail.metrics.employees

1,800+

competitors.competitorDetail.metrics.revenue

$100M+

competitors.competitorDetail.metrics.headquarters

600 W Chicago Ave, Suite 510, Chicago, IL 60654, USA

competitors.competitorDetail.metrics.marketShare

Significant presence in the US precision oncology market

competitors.competitorDetail.metrics.usp

Tempus combines advanced AI-driven analytics with a vast, integrated clinical and molecular data platform, offering insights that drive personalized cancer care.

competitors.competitorDetail.metrics.pricingModel

Fee-for-service for testing; SaaS/data licensing for analytics

competitors.competitorDetail.metrics.productLines
  • Tempus xT Comprehensive Genomic Profiling
  • Tempus Lens Clinical Trial Matching
  • Tempus O Comprehensive Oncology Data
  • Tempus One Next-Gen Data Platform
competitors.competitorDetail.metrics.technologyStack
  • Python
  • TensorFlow
  • SQL
  • AWS
  • Next-gen sequencing technology
  • HL7 FHIR interoperability

competitors.competitorDetail.metrics.marketPositioning

Premium, enterprise-grade health data & analytics for hospitals and pharma.

competitors.competitorDetail.metrics.keyCustomerSegments
  • Large hospital systems
  • Academic medical centers
  • Oncology clinics
  • Pharmaceutical R&D teams
competitors.competitorDetail.metrics.distributionChannels
  • Direct Sales (hospital partnerships)
  • Clinical network integrations
  • Pharmaceutical research collaborations
competitors.competitorDetail.metrics.marketingStrategies
  • Conference presentations
  • Thought leadership in precision medicine
  • Academic partnerships and publications
  • Provider network outreach
competitors.competitorDetail.metrics.keyPartnerships
  • Mayo Clinic (Research/Integration)
  • Cleveland Clinic (Provider Network)
  • Pfizer (Pharmaceutical Research)

  • Next-generation sequencing
  • AI-driven molecular analytics
  • Integrated clinical-genomic database
  • Oncology decision-support tools
  • Data-driven clinical trial matching

competitors.competitorDetail.metrics.strengths
  • Comprehensive clinical and molecular data platform
  • Cutting-edge AI and analytics capabilities
  • Partnerships with leading academic medical centers
  • Significant investment and rapid scaling
competitors.competitorDetail.metrics.weaknesses
  • High cost of precision medicine solutions
  • Heavy competition from established diagnostic labs
  • Integration challenges with hospital EMRs
competitors.competitorDetail.metrics.opportunities
  • Expansion into other disease areas (neurology, cardiology)
  • International market growth
  • Development of new AI-based clinical tools
competitors.competitorDetail.metrics.threats
  • Regulatory changes in genetic testing
  • Rising competition in precision medicine
  • Privacy concerns surrounding patient data
competitors.competitorDetail.financials

competitors.competitorDetail.metrics.growthRateYOY

High double-digit (%)

competitors.competitorDetail.metrics.profitMargin

Not publicly disclosed

competitors.competitorDetail.metrics.customerAcquisitionCost

$2,000+ per hospital/partner

competitors.competitorDetail.metrics.customerLifetimeValue

Varies - multimillion-dollar contracts possible

competitors.competitorDetail.metrics.churnRate

Low – most contracts are multi-year

competitors.competitorDetail.metrics.fundingRounds
competitors.competitorDetail.metrics.fundingStagecompetitors.competitorDetail.metrics.fundingAmountcompetitors.competitorDetail.metrics.fundingDate
Series A$8M2016-03-01
Series B$30M2017-04-03
Series C$70M2017-11-28
Series D$110M2018-03-20
Series F$200M2020-12-14
competitors.competitorDetail.metrics.companyCultureHighlights
  • Mission-driven
  • Innovative
  • Collaborative research environment
  • Commitment to diversity and inclusion
  • Growth-oriented
competitors.competitorDetail.metrics.awardsAndRecognition
  • CB Insights Digital Health 150 (2022) - CB Insights
  • Chicago Innovation Award (2021) - Chicago Innovation
competitors.competitorDetail.metrics.customerReviewsSummary
competitors.competitorDetail.reviews.titlecompetitors.competitorDetail.reviews.ratingcompetitors.competitorDetail.reviews.viewAll
G2 4.8/565
Capterra 4.7/548
competitors.competitorDetail.metrics.recentNews
competitors.competitorDetail.news.titlecompetitors.competitorDetail.news.publishedOncompetitors.competitorDetail.news.readMore
Tempus Launches New Platform for Precision Psychiatry2024-02-08Business Wire
Tempus Raises New Funding to Expand Data Capabilities2023-12-15Forbes
competitors.competitorDetail.metrics.socialMedia